Judge Rules GlaxoSmithKline Cannot Claim Preemption in Paxil Case

Judge Rules Against Paxil Preemption Drug Toxic Chemicals

Free Case Evaluation From An Experienced Drug Liability Attorney.

Judge Rules GlaxoSmithKline Cannot Claim Preemption in Paxil Case

Eli Lilly, the manufacturer of the antipsychotic drug Zyprexa, has said that it simply doesn’t agree with the allegations of several states’ attorney generals that it has illegally marketed the drug, concealed its harmful side effects, and encouraged doctors to prescribe it for unapproved uses. However, recent testimony against the company by an FDA official and nine pending state lawsuits don’t hold out much promise for the manufacturer.
What is Zyprexa?
Introduced in 1996, Zyprexa (olanzapine) is prescribed to treat schizophrenia, acute mixed or manic episodes of bipolar disorder and maintaining the treatment of bipolar disorder. According to news reports, Eli Lilly has concealed the harmful health risks associated with Zyprexa – including an increased risk for diabetes. The company allegedly told its sales representatives to ‘play down’ the side effects as sales of the drug were high – over $4 billion last year. It is estimated that 20 million people have taken the drug worldwide.
Nine states suing manufacturer?
Nine states have sued Eli Lilly over these practices – Connecticut being the latest. Connecticut’s long time Attorney General, Richard Blumenthal, has alleged:
Eli Lilly allegedly corrupted physicians, pharmacies and administrators at nursing homes and youth detention centers as part of a massive illegal marketing campaign to promote Zyprexa for unapproved off-label uses, including for the treatment of children.
Eli Lilly has denied the charges and is urging patients to continue using the drug. However, the company has already agreed to pay $1.2 billion to settle nearly 30,000 lawsuits for people who alleged to have developed diabetes or other diseases related to the drug. Thousands of lawsuits are still pending.
FDA Official Testifies Against Eli Lilly
An official from the FDA (Food and Drug Administration) testified against Eli Lilly in an Alaska case, the first of the nine to go to trial. According to news reports, the official told the jury that Eli Lilly wasn’t sufficiently concerned about patient welfare. He was quoted as saying, “Simply put, it’s putting profit over the concern of the consumer.”
If you’ve been injured by Zyprexa, contact an attorney whose practice focuses in this area of law to discuss your situation. Consultations are free, without obligation and strictly confidential. To contact a qualified attorney, please click here.

Read more for related video clips.

YouTube responded with an error: The request cannot be completed because you have exceeded your <a href="/youtube/v3/getting-started#quota">quota</a>.